Navigation Links
Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting

SAN DIEGO, May 14, 2007 /PRNewswire-FirstCall/ -- Shire plc , the market leader in treatments for Attention-Deficit/Hyperactivity Disorder (ADHD), announced that it will present key scientific data on its ADHD treatment portfolio at the American Psychiatric Association (APA) annual meeting to be held May 19 to 24 in San Diego.

"The upcoming clinical research to be presented at APA reaffirms Shire's commitment to understanding the science of ADHD treatment," said Eliseo Salinas, Chief Scientific Officer and Executive Vice President, Global R&D. "We are looking forward to sharing new scientific data from clinical trials involving our ADHD portfolio of treatments with the medical community."

Shire's portfolio of ADHD treatments includes VYVANSE(TM) (lisdexamfetamine dimesylate), the first prodrug stimulant, which is planned to launch 2Q 2007, DAYTRANA(TM) (methylphenidate transdermal system), the first and only ADHD patch, and ADDERALL XR(R) (mixed salts of a single-entity amphetamine product), a long-acting formulated stimulant. Additional ADHD treatments under development by Shire include SPD465 (triple-bead mixed amphetamine salts) and SPD503 (guanfacine HCl extended release).

A summary of the key scientific presentations is provided below. Information about the data presentations mentioned in this release is embargoed until the respective presentation sessions have taken place at the APA annual meeting.

    VYVANSE (lisdexamfetamine dimesylate):


    May 23, 2007; 3:00 p.m. PDT (6:00 p.m. EDT)

    Long-Term Effectiveness and Safety of Lisdexamfetamine Dimesylate (LDX) in

    Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

    APA Poster# NR739


    May 23, 2007; 3:00 p.m. PDT (6:00 p.m. EDT)

    Improved Interpatient Pharmacokinetic Variability of Lisdexamfetamine

    Dimesylate Compared With Mixed Amphetamine Salts Extended Release (MAS XR)


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:12/19/2014)... WAYNE, N.J. , Dec. 19, 2014  In the Friday, ... , a 16-page supplement dedicated to Healthcare Information Technology (HIT) features ... innovation in Healthcare IT in partnership with several leading healthcare organizations. ... be distributed across several major metropolitan markets, such as ... Washington DC / Baltimore , Minneapolis ...
(Date:12/19/2014)... LONDON , December 19, 2014 ... authentication services in the World announced the appointment of ... Anthony R. Vonsée, as Chief Channels and Partner Officer. ... Datanomic since 2004 through to its acquisition by Oracle ... Development Director at Geneva and ...
(Date:12/19/2014)... , Dec. 19, 2014  Newport Corporation ... Siddhartha Kadia, Ph.D. has joined the company,s Board ... Executive Officer and a director of Evans Analytical ... testing, evaluation and analytical services to companies in ... Prior to joining Evans Analytical Group, Dr. Kadia ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... ANF Group, Inc ., a South Florida based ... 170,000-square-foot Joe DiMaggio Children,s Hospital – the first free ... (Photo: http://photos.prnewswire.com/prnh/20110614/FL18288 ) The hospital,s ... designed to earn Gold Leadership in Energy and Environment ...
... June 14, 2011 CVS/pharmacy provides ... at more than 7,200 convenient locations nationwide. Shoppers have come ... larger-than-ever selection of gifts, goods and everyday needs. From popular ... the hottest gear and thoughtful keepsakes perfect for every dad, ...
Cached Medicine Technology:ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 3
(Date:12/21/2014)... New York, NY (PRWEB) December 21, 2014 ... is nearing 1,400 in a consolidated litigation underway in ... court documents, a total of 1,375 claims involving the ... County Superior Court. These lawsuits were filed by women ... claim to have led to uterine perforations and other ...
(Date:12/21/2014)... Over the past 39 years, NES Health ... emergency departments across the nation, from quality of medical ... into an innovative suite of tools, systems, and programs ... the patient experience. , NES Health, a leading ... services for hospitals, announced the development and launch of ...
(Date:12/21/2014)... December 21, 2014 CannabisClassifieds.com celebrates marijuana’s new ... The only one of its kind, the site has provided ... marijuana for 14 years running. It uniquely combines the ... make cannabis readily available to the masses. Assuring the ... the golden ring of public approval. , Shane ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
(Date:12/20/2014)... LunaDress has recently announced its 2015 collection of ... on all of its special occasion dresses & wedding apparel. ... wedding gown. If you have no idea of what to ... different wedding dress styles and our dress experts are here ... current special offer, up to 80% off," the CEO of ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
... 15, 2007, Philadelphia, PA Researchers found that mesalamine ... with a decrease in incidence of colorectal cancer when ... at the 72nd Annual Scientific Meeting of the American ... Detroit matched 16 patients with ulcerative colitis and Crohns ...
... 2007 Post-hoc and other analyses of secondary endpoints ... plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis ... in patients with mild to moderate ulcerative colitis. These ... open-label 12-14 month extension study, are being presented this ...
... toothbrush may be the,ultimate plaque fighting tool, but it ... Sonicare and GfK Roper reveals that more than half,(54 ... fell on,the bathroom floor, despite voting the bathroom as ... percent). In addition, nine percent of men,admitted to reusing ...
... Strengthen Strategic Consulting ... Canada, MOUNTAIN VIEW, Calif., Oct. 15 ... of software,strategic consulting, and regulatory services for optimizing ... scientific consulting,services practices with three new hires. Pharsight ...
... total sleep times, both habitually and on the morning after ... higher than objectively measured sleep times, according to a study ... Clinical Sleep Medicine (JCSM). , Graciela E. Silva, PhD, of ... were 40 years of age or older. The participants ...
... October 15 Sanofi Pasteur, the,vaccines division ... Institut Pasteur to develop a vaccine against ... have access to antigens,identified by Institut Pasteur ... the most deadly malaria infections. Sanofi Pasteur,intends ...
Cached Medicine News:Health News:Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 2Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 3Health News:Pharsight Expands Global Consulting Services Teams 2Health News:Pharsight Expands Global Consulting Services Teams 3Health News:People overestimate their self-reported sleep times compared to measures by a sleep test 2Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 2Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 3
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Medicine Products: